Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.
about
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerSafety of Nanoparticles in MedicineCurrent Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Composite nanoparticles for gene delivery.Smart polymeric nanoparticles for cancer gene delivery.Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.Polyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging.Ligand-targeted theranostic nanomedicines against cancerDermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivoA pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.Polysaccharide-based nanoparticles for theranostic nanomedicine.Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.Recent advances in cyclodextrin delivery techniques.Recent advances in siRNA delivery.High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.Highly efficient siRNA delivery from core-shell mesoporous silica nanoparticles with multifunctional polymer caps.Genotoxicity of mesoporous silica nanoparticles in human embryonic kidney 293 cells.Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells.A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.Size-controlled and redox-responsive supramolecular nanoparticles.Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.Multidisciplinary efforts driving translational theranostics.A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings.Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles.Mesoporous silica nanoparticles for drug and gene delivery.Integration of polymers in the pore space of mesoporous nanocarriers for drug deliveryNon-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
P2860
Q26784324-4E8B323C-8F99-4FD0-B389-5E989D12E8EBQ28083076-099BDCEB-9E78-45F9-9675-DF2188926CD8Q30362001-67055EE6-781F-4A99-BDDB-6C6402161B28Q30374988-034EEA81-3311-47D3-B603-A986BB39BF16Q35057532-59EB3F9E-8421-4F5B-9ADA-D20CF59CA28AQ35227495-A01E1B29-5ABA-4B3B-8479-D849E3840A95Q35831166-9D595E3D-670D-4510-9FE9-2A27F02E2DA6Q35895637-A055CF0F-B9FE-417E-A25F-67821A5BA159Q35908995-92C014BB-EBD6-426A-A46E-350B6E92BA5AQ36360773-4BA5F777-BAF5-4122-95F0-A223001140D3Q36534206-35212B6B-0927-4263-A24D-4A55E7B736BCQ36561709-559F1A71-2284-41F0-9348-FA645653E298Q36703343-8DE63C93-6EAC-4A7B-B38B-D81F8DDA322AQ36784555-0F2DB916-D83D-445D-A0DB-8445F3C67282Q38384069-89794177-0256-4DEB-B3EE-3153EDA0E911Q38534300-722C8E0A-814F-4D09-B3FE-05A9EA03D571Q38648525-F7E2363D-C756-477D-84BC-55B69D870FF9Q38651811-1DEA29C0-0DF9-4525-97C7-9B6BADD30F4AQ38717131-42F4D0DC-FB88-4F9A-A946-EB22CCEFC015Q38799002-F4BA02D7-0A75-4276-B3E1-8B55A885165CQ38920517-07097D8A-0CEA-4D69-9D36-63607F13DC97Q38930223-7BB4C2F7-9396-4081-9EB2-6D615D3027C2Q41112245-DEB25B84-9453-4074-9372-DCDFB7B6DACCQ41875899-D778FEB2-39CF-4590-9956-ED886B36BB53Q42429773-913C2473-599E-4953-B8A1-6042E503DE9FQ42927091-5F456A2C-CCF1-4A38-B65C-3071A762065EQ42972230-3987835C-6ABA-4747-911A-DE941E64F644Q47295411-8BAA756B-2898-4122-BC4A-B0155DFC0FB7Q49389681-077168A4-43B4-4845-96C5-90D837F96165Q50921061-9AF6DF57-505C-4265-A88C-E8A18EB86DFAQ55155032-A3C9E41A-FF15-4AD6-8E6A-8FF6E5B2D326Q57368237-B2880B20-0AEF-466B-9ABF-C07EF3461DD1Q58728426-9DD16BD3-49FF-4533-8869-C2BF022032D6
P2860
Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@ast
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@en
type
label
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@ast
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@en
prefLabel
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@ast
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@en
P2093
P2860
P50
P356
P1433
P1476
Cyclodextrin and polyethylenim ...... of siRNA cancer therapeutics.
@en
P2093
Chaofeng Mu
Dickson Kirui
Haifa Shen
Han-Cheon Kim
Jianliang Shen
Liang-Nian Ji
P2860
P304
P356
10.7150/THNO.8263
P577
2014-02-15T00:00:00Z